Although dysregulated (elevated) RAD51 could impact growth of cancer cells through possible impact on cell cycle, no changes in cell cycle were detected following overexpression of RAD51 in normal (HDF) or a breast cancer cell line tested (Figure S6). This evidence concerns the gene RAD51 and breast cancer.